Guizhou University of Traditional Chinese Medicine, Guiyang, China.
The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang, China.
Biotechnol Genet Eng Rev. 2023 Oct;39(2):1107-1127. doi: 10.1080/02648725.2023.2167765. Epub 2023 Feb 3.
The purpose of this study is to investigate the main active components and potential mechanisms of action of Yiyi Fuzi Baijiang powder against colorectal cancer by network pharmacology and molecular docking. Firstly, the TCMSP database was used to search for the active ingredients and targets of Yiyi Fuzi Baijiang powder, and colorectal cancer disease genes were collected through GeneCards and DisGeNET database. The intersection genes between Yiyi Fuzi Baijiang powder and colorectal cancer were then found using the web program Venny 2.1.0. Next, a protein interaction network was constructed using the STRING database, and Cytoscape 3.7.1 was used to screen and display the main targets. The David database uses functional Gene Ontology (GO) and KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway enrichment analysis to examine key targets. To filter the primary active components, an "active ingredient-target-pathway" network was built using Cytoscape 3.7.1. Finally, AutoDockTool and PyMOL were used to validate molecular docking. Yiyi Fuzi Baijiang powder and CRC yield 176 intersection targets. Quercetin, luteolin,kaempferol, stigmasterol, and β-sitosterol are the main active substances, whereas HSP90AA1, TP53, JUN, AKT1, and MAPK1 are the main targets. Yiyi Fuzi Baijiang powder may influence the PI3K-Akt signaling pathway, TNF signaling route, and IL-17 signaling pathway, which are involved in transcription, gene expression, apoptosis and proliferation regulation, among other biological processes, according to GO and KEGG enrichment analyses. The results of the molecular docking demonstrated that all of the major targets could be strongly bound by the core active chemicals in Yiyi Fuzi Baijiang powder. By simultaneously controlling several active components' target genes and associated signaling pathways, Yiyi Fuzi Baijiang powder may slow the advancement of colorectal cancer by controlling apoptosis, proliferation, and the binding of proteins and enzymes.
本研究旨在通过网络药理学和分子对接技术,探讨一一附子白降粉防治大肠癌的主要活性成分及潜在作用机制。首先,利用 TCMSP 数据库搜索一一附子白降粉的活性成分和靶点,通过 GeneCards 和 DisGeNET 数据库收集大肠癌疾病基因。然后,利用 Venny 2.1.0 网络程序寻找一一附子白降粉与大肠癌的交集基因。接下来,利用 STRING 数据库构建蛋白质相互作用网络,并用 Cytoscape 3.7.1 筛选和显示主要靶点。利用 David 数据库进行功能基因本体论(GO)和京都基因与基因组百科全书(KEGG)通路富集分析,筛选关键靶点。为了筛选主要的活性成分,利用 Cytoscape 3.7.1 构建“活性成分-靶点-通路”网络。最后,利用 AutoDockTool 和 PyMOL 对分子对接进行验证。一一附子白降粉与 CRC 有 176 个交集靶点。槲皮素、木樨草素、山奈酚、豆甾醇和β-谷甾醇是主要的活性物质,而 HSP90AA1、TP53、JUN、AKT1 和 MAPK1 是主要的靶点。GO 和 KEGG 富集分析表明,一一附子白降粉可能通过影响 PI3K-Akt 信号通路、TNF 信号通路和 IL-17 信号通路,参与转录、基因表达、凋亡和增殖调控等生物学过程。分子对接的结果表明,一一附子白降粉的主要靶点都能与核心活性成分强烈结合。一一附子白降粉可能通过调控多个活性成分的靶基因及其相关信号通路,同时控制蛋白质和酶的结合,从而减缓大肠癌的进展。